Your browser doesn't support javascript.
loading
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.
Hall, Victoria G; Ferreira, Victor H; Ku, Terrance; Ierullo, Matthew; Majchrzak-Kita, Beata; Chaparro, Cecilia; Selzner, Nazia; Schiff, Jeffrey; McDonald, Michael; Tomlinson, George; Kulasingam, Vathany; Kumar, Deepali; Humar, Atul.
Afiliación
  • Hall VG; University Health Network, Toronto, ON, Canada atul.humar@uhn.ca.
  • Ferreira VH; University Health Network, Toronto, ON, Canada atul.humar@uhn.ca.
  • Ku T; University Health Network, Toronto, ON, Canada atul.humar@uhn.ca.
  • Ierullo M; University Health Network, Toronto, ON, Canada atul.humar@uhn.ca.
  • Majchrzak-Kita B; University Health Network, Toronto, ON, Canada atul.humar@uhn.ca.
  • Chaparro C; University Health Network, Toronto, ON, Canada atul.humar@uhn.ca.
  • Selzner N; University Health Network, Toronto, ON, Canada atul.humar@uhn.ca.
  • Schiff J; University Health Network, Toronto, ON, Canada atul.humar@uhn.ca.
  • McDonald M; University Health Network, Toronto, ON, Canada atul.humar@uhn.ca.
  • Tomlinson G; University Health Network, Toronto, ON, Canada atul.humar@uhn.ca.
  • Kulasingam V; University Health Network, Toronto, ON, Canada atul.humar@uhn.ca.
  • Kumar D; University Health Network, Toronto, ON, Canada atul.humar@uhn.ca.
  • Humar A; University Health Network, Toronto, ON, Canada atul.humar@uhn.ca.
N Engl J Med ; 385(13): 1244-1246, 2021 09 23.
Article en En | MEDLINE | ID: mdl-34379917

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunización Secundaria / Receptores de Trasplantes / Inmunogenicidad Vacunal / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: N Engl J Med Año: 2021 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunización Secundaria / Receptores de Trasplantes / Inmunogenicidad Vacunal / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: N Engl J Med Año: 2021 Tipo del documento: Article País de afiliación: Canadá